Related references
Note: Only part of the references are listed.Triptan persistency among newly initiated users in a pharmacy claims database
Bozena J. Katic et al.
CEPHALALGIA (2011)
Headache and migraine EFNS guideline
[Anonymous]
PROGRESS IN NEUROLOGY AND PSYCHIATRY (2010)
Rates and Predictors of Starting a Triptan: Results From the American Migraine Prevalence and Prevention Study
Marcelo E. Bigal et al.
HEADACHE (2010)
The acute treatment of episodic and chronic migraine in the USA
M. E. Bigal et al.
CEPHALALGIA (2009)
Migraine prevalence, disease burden, and the need for preventive therapy
R. B. Lipton et al.
NEUROLOGY (2007)
Prevalence and burden of migraine in the United States: Data from the American Migraine Study II
RB Lipton et al.
HEADACHE (2001)
Validity of the Migraine Disability Assessment (MIDAS) score in comparison to a diary-based measure in a population sample of migraine sufferers
WF Stewart et al.
PAIN (2000)
Practice parameter: Evidence-based guidelines for migraine headache (an evidence-based review) - Report of the Quality Standards Subcommittee of the American Academy of Neurology
SD Silberstein
NEUROLOGY (2000)
Share Paper
